⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of UQUIFA and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
UQUIFA
↗Barcelona, Spain
UQUIFA is a global Contract Development and Manufacturing Organization (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates. With over 85 years of experience, the company supports the pharmaceutical and animal health industries from proof-of-concept through to commercial-scale manufacturing.
The company operates manufacturing sites across Spain, Mexico, and Hungary (via its subsidiary Soneas Chemicals). UQUIFA is recognized for its cGMP-compliant facilities, which have been inspected and approved by major regulatory authorities including the US FDA, EMA, and others. It is a subsidiary of Vivimed Labs Limited.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Founded:1936
Ownership:subsidiary
Status:operating
FUNDING
Total Raised:$42.5M
Investors:OrbiMed
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Vivimed Labs Limited
Acquired By:Vivimed Labs Limited
Subsidiaries:Soneas Chemicals Ltd
Key Partnerships:Gilead Lifesciences, GSK, Mylan, Esteve Quimica, Apotex
COMPETITION
Position:Niche Player
Competitors:Laurus Labs, Symbiotec, Hikal
LEADERSHIP
Key Executives:
Saurabh Gurnurkar - Managing Director
LINKS
Website:uquifa.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with UQUIFA. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.